Integrated QSAR Models for Prediction of Serotonergic Activity: Machine Learning Unveiling Activity and Selectivity Patterns of Molecular Descriptors.

Mordred machine learning molecular descriptors selectivity and activity serotonin receptors statistical analysis

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
01 Mar 2024
Historique:
received: 08 02 2024
revised: 27 02 2024
accepted: 28 02 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: epublish

Résumé

Understanding the features of compounds that determine their high serotonergic activity and selectivity for specific receptor subtypes represents a pivotal challenge in drug discovery, directly impacting the ability to minimize adverse events while maximizing therapeutic efficacy. Up to now, this process has been a puzzle and limited to a few serotonergic targets. One approach represented in the literature focuses on receptor structure whereas in this study, we followed another strategy by creating AI-based models capable of predicting serotonergic activity and selectivity based on ligands' representation by molecular descriptors. Predictive models were developed using Automated Machine Learning provided by Mljar and later analyzed through the SHAP importance analysis, which allowed us to clarify the relationship between descriptors and the effect on activity and what features determine selective affinity for serotonin receptors. Through the experiments, it was possible to highlight the most important features of ligands based on highly efficient models. These features are discussed in this manuscript. The models are available in the additional modules of the SerotoninAI application called "Serotonergic activity" and "Selectivity".

Identifiants

pubmed: 38543243
pii: pharmaceutics16030349
doi: 10.3390/pharmaceutics16030349
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Smart Growth Operational Programme POIR 4.2
ID : POIR.04.02.00-00-D023/20
Organisme : "Excellence Initiative-Research University" at Jagiellonian University
ID : qLIFE Priority Research Area
Organisme : Jagiellonian University
ID : N42/DBS/000261

Auteurs

Natalia Łapińska (N)

Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, 30-688 Kraków, Poland.
Doctoral School of Medicinal and Health Sciences, Jagiellonian University Medical College, 31-530 Kraków, Poland.
Bioinformatics and In Silico Analysis Laboratory, Center for the Development of Therapies for Civilization and Age-Related Diseases (CDT-CARD), 8 Skawińska St., 31-066 Kraków, Poland.

Adam Pacławski (A)

Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, 30-688 Kraków, Poland.

Jakub Szlęk (J)

Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, 30-688 Kraków, Poland.

Aleksander Mendyk (A)

Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, 30-688 Kraków, Poland.
Bioinformatics and In Silico Analysis Laboratory, Center for the Development of Therapies for Civilization and Age-Related Diseases (CDT-CARD), 8 Skawińska St., 31-066 Kraków, Poland.

Classifications MeSH